fluorodeoxyglucose f18 has been researched along with technetium tc 99m hydroxymethylene diphosphonate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumura, T; Ichiya, Y; Kawai, Y; Koga, H; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M | 1 |
| Cho, I; Fukuchi, K; Hayashida, K; Imakita, S; Ishida, Y; Kume, N; Kumita, S; Shimotsu, Y; Takamiya, M; Toba, M | 1 |
| Börner, AR; Flügel, M; Knapp, WH; Kühnel, G; Redeker, J; Weckesser, E | 1 |
| Aoki, J; Endo, K; Ichikawa, A; Inoue, T; Koyama, K; Matsubara, K; Oriuchi, N; Sato, N; Suzuki, H; Tomiyoshi, K | 1 |
| Fukuchi, K; Hayashida, K; Ishida, Y; Yamaguchi, M | 1 |
| Cesnik, R; Frühwald, F; Leitha, T; Steiner, E | 1 |
| Hamdan, A; Keller, A; Taylor, S; Toman, J | 1 |
| Fogelman, I | 1 |
| Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Suzuki, T; Taniike, K; Ushijima, Y; Yamada, K | 1 |
| Abe, K; Baba, S; Hayashi, K; Honda, H; Koga, H; Kuwabara, Y; Sasaki, M; Takahashi, N | 1 |
| Fujimoto, R; Fujita, T; Hara, T; Higashi, T; Ishizu, K; Kawase, S; Kawashima, H; Lyshchik, A; Nakamoto, Y; Saga, T; Togashi, K | 1 |
| Arce, K; Assael, LA; Markiewicz, MR; Weissman, JL | 1 |
| Chezal, JM; Dauplat, MM; Gouin, F; Heymann, D; Miot-Noirault, E; Redini, F | 1 |
| Chong, A; Ha, JM; Hong, R; Kwon, SY | 1 |
| Kim, SH; Song, BI; Won, KS | 1 |
| De Marini, P; Fornecker, LM; Laplace, A; Matuszak, J; Namer, IJ | 1 |
| Hamzah, F; Khoo, AC; Ong, CK | 1 |
| Blondet, C; Heimburger, C; Matuszak, J; Somme, F | 1 |
1 review(s) available for fluorodeoxyglucose f18 and technetium tc 99m hydroxymethylene diphosphonate
| Article | Year |
|---|---|
Imaging findings in bisphosphonate-related osteonecrosis of jaws.
Topics: Bone Density Conservation Agents; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Magnetic Resonance Imaging; Osteonecrosis; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2009 |
2 trial(s) available for fluorodeoxyglucose f18 and technetium tc 99m hydroxymethylene diphosphonate
| Article | Year |
|---|---|
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2005 |
15 other study(ies) available for fluorodeoxyglucose f18 and technetium tc 99m hydroxymethylene diphosphonate
| Article | Year |
|---|---|
Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
Topics: Adult; Bone Neoplasms; Deoxyglucose; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Ribs; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1993 |
Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia.
Topics: Bone Density; Facial Bones; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Glucose; Humans; Hyperplasia; Middle Aged; Radiopharmaceuticals; Sclerosis; Skull; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
[Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
Topics: Aged; Carbon Radioisotopes; Diagnosis, Differential; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution; Tomography, Emission-Computed | 2000 |
Usefulness of dual-head coincidence gamma camera with thick NaI crystals for nuclear oncology: comparison with dedicated PET camera and conventional gamma camera with thin NaI crystals.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Iodide; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2001 |
Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
Topics: Bone Marrow Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Ilium; Lung Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Pelvic Bones; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2004 |
Nuclear imaging of an extraskeletal retroperitoneal osteosarcoma: respective contribution of 18FDG-PET and (99m)Tc oxidronate (2005:1b).
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Technetium Tc 99m Medronate | 2005 |
Osteoblastic bone metastases in breast cancer: is not seeing believing?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2006 |
Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma.
Topics: Animals; Bone Neoplasms; Bone Remodeling; Cell Growth Processes; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2012 |
Variations in findings on (18) F-FDG PET/CT, Tc-99m HDP bone scan and WBC scan in chronic multifocal osteomyelitis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Leukocyte Count; Lumbar Vertebrae; Male; Osteomyelitis; Positron-Emission Tomography; Radionuclide Imaging; Sternum; Technetium Tc 99m Medronate; Thoracic Vertebrae | 2014 |
Colon visualization on (99m)Tc-HDP whole-body bone scan due to sigmoid colon cancer-related enterovesical fistula.
Topics: Aged; Bone and Bones; Carcinoma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Fistula; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder Fistula; Whole Body Imaging | 2015 |
Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions.
Topics: Bone and Bones; Erythrocyte Transfusion; Fluorodeoxyglucose F18; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Platelet Transfusion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Young Adult | 2016 |
Incidental Sclerosing Pneumocytoma Detected on Bone Scintigraphy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Osteomyelitis; Positron Emission Tomography Computed Tomography; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2017 |
Evaluation of Oxalate Osteopathy Secondary to Hyperoxaluria With 18F-FDG PET/CT and 99mTc-HMDP Bone Scan.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hyperoxaluria, Primary; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Medronate | 2019 |